Partner Content Partner Content The Difference Between KOL Identification And KOL Mapping KOL identification and KOL mapping are often spoken about together, often treated as the same entity would simply a difference in terminology. They are however very different, yet synergistic.
Partner Content Partner Content Sector specialism is essential for clinical labeling solutio... Supply chain partners need specialist knowledge
Partner Content Partner Content RxSource optimizes clinical labeling process with PRISYM 360... How PRISYM 360 streamlined RxSource's labeling
Partner Content Partner Content Measuring And Tracking KOL Advocacy Track and Measure your KOL Advocacy
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.